# FDA Inspection 1168163 - Yabao Pharmaceutical Co., Ltd. Beijing - April 20, 2022

Source: https://www.keypedia.com/records/fda_inspections/yabao-pharmaceutical-co-ltd-beijing/f0d187ef-2f77-43c0-85b9-71d81ce83941
Source feed: FDA_Inspections

> FDA inspection 1168163 of Yabao Pharmaceutical Co., Ltd. Beijing, April 20, 2022. Classification: Voluntary Action Indicated (VAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1168163
- Company Name: Yabao Pharmaceutical Co., Ltd. Beijing
- Inspection Date: 2022-04-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1309898 - 2026-03-06](https://www.keypedia.com/records/fda_inspections/yabao-pharmaceutical-co-ltd-beijing/fcb76e6e-3237-4823-b156-b82f1caf1215)
- FDA Inspection 923752 - 2015-04-03
- FDA Inspection 849070 - 2013-08-16

Company: https://www.keypedia.com/companies/yabao-pharmaceutical-co-ltd-beijing/0abb3f06-8186-4497-83ba-1cd93ffce2a6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c